For the vaccination of healthy, susceptible horses 6 months of age or older, including pregnant mares, as an aid in the reducation of respiratory disease due to equine herpesvirus type 1 (EHV-1) and type 4 (EHV-4) and by equine influenza types A1 and A2 viruses.
Shake well before use.
Using aseptic technique, inoculate horses intramuscularly with a 2ml dose.
Administer a second 2ml dose intramuscularly in 3-4 weeks using a different injection site.
Administer a third 2ml dose in 3-4 weeks by either the intramuscular or intranasal route.
Revaccinate annually and prior to anticipated exposure, by either the intramuscular or intranasal route.
Dosage and Administration